Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Daily Top 10 COVID-19 publications

Deutsch | English | Español | Français | Italiano | Português; | Tiếng Việt | Türkçe

  Malignant Lymphoma

  Free Subscription

Articles published in Eur J Haematol

Retrieve available abstracts of 59 articles:
HTML format

Single Articles

    April 2020
  1. LACOUT C, Orvain C, Seegers V, De Vries M, et al
    R-DHA-oxaliplatin (R-DHAOx) versus R-DHA-cisplatin (R-DHAP) regimen in B-cell lymphoma treatment.
    Eur J Haematol. 2020 Apr 17. doi: 10.1111/ejh.13429.
    PubMed     Abstract available

  2. KARI EJM, Kuusisto MEL, Honkavaara P, Hakalahti A, et al
    Thioredoxin-1 as a biological predictive marker for selecting diffuse large B-cell lymphoma patients for etoposide-containing treatment.
    Eur J Haematol. 2020 Apr 5. doi: 10.1111/ejh.13419.
    PubMed     Abstract available

    February 2020
  3. IANNITTO E, Romano A, Scalzulli PR, Bonanno V, et al
    Brentuximab vedotin in association with Bendamustine in refractory or multiple relapsed Hodgkin Lymphoma. A retrospective real-world study.
    Eur J Haematol. 2020 Feb 27. doi: 10.1111/ejh.13400.
    PubMed     Abstract available

    January 2020
  4. ZHOU X, Wuchter P, Egerer G, Kriegsmann M, et al
    Serological hepatitis B virus (HBV) activity in patients with HBV infection and B-cell non-Hodgkin's lymphoma.
    Eur J Haematol. 2020 Jan 21. doi: 10.1111/ejh.13388.
    PubMed     Abstract available

  5. XU J, Liu JL, Medeiros LJ, Huang W, et al
    MYC Rearrangement and MYC/BCL2 Double Expression but not Cell-of-Origin Predict Prognosis in R-CHOP-Treated Diffuse Large B Cell Lymphoma.
    Eur J Haematol. 2020 Jan 15. doi: 10.1111/ejh.13384.
    PubMed     Abstract available

  6. ZHOU X, Steinhardt MJ, Dull J, Krummenast F, et al
    Obinutuzumab and venetoclax induced complete remission in a patient with ibrutinib-resistant non-nodal leukemic mantle cell lymphoma.
    Eur J Haematol. 2020 Jan 10. doi: 10.1111/ejh.13382.
    PubMed     Abstract available

    December 2019
  7. MICHOT JM, Annereau M, Danu A, Legoupil C, et al
    High-Dose Cyclophosphamide for hard-to-treat patients with Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma, a phase II result.
    Eur J Haematol. 2019 Dec 14. doi: 10.1111/ejh.13369.
    PubMed     Abstract available

  8. GUTIERREZ A, Bento L, Diaz-Lopez A, Barranco G, et al
    Evaluation of The MD Anderson Tumor Score for Diffuse Large B-cell Lymphoma in the Rituximab Era.
    Eur J Haematol. 2019 Dec 5. doi: 10.1111/ejh.13364.
    PubMed     Abstract available

  9. KAWAJIRI A, Kitano S, Maeshima AM, Inamoto Y, et al
    Association of CD204(+) macrophages with poor outcomes of malignant lymphomas not in remission treated by allogeneic HCT.
    Eur J Haematol. 2019;103:578-587.
    PubMed     Abstract available

    November 2019
  10. ABDULLA M, Guglielmo P, Hollander P, Astrom G, et al
    Prognostic impact of abdominal lymph node involvement in diffuse large B-cell lymphoma.
    Eur J Haematol. 2019 Nov 30. doi: 10.1111/ejh.13361.
    PubMed     Abstract available

  11. MERCADAL S, Sancho JM, Climent F, Tapia G, et al
    Long-term Outcome comparing Histological Grades of Follicular Lymphoma Patients Treated with Immunochemotherapy as First Line Therapy. A Retrospective Analysis from Two Institutions".
    Eur J Haematol. 2019 Nov 26. doi: 10.1111/ejh.13359.
    PubMed     Abstract available

  12. TANEJA A, Kumar V, Chandra AB
    Primary Renal Lymphoma: A Population-based Analysis Using the SEER Program (1973-2015).
    Eur J Haematol. 2019 Nov 26. doi: 10.1111/ejh.13360.
    PubMed     Abstract available

    October 2019
  13. MALENDA A, Kolkowska-Lesniak A, Pula B, Dlugosz-Danecka M, et al
    Outcomes of treatment with dose-adjusted EPOCH-R or R-CHOP in primary mediastinal large B-cell lymphoma.
    Eur J Haematol. 2019 Oct 13. doi: 10.1111/ejh.13337.
    PubMed     Abstract available

    September 2019
  14. ATALLAH-YUNES SA, Murphy D, Abdelmalak R, Mantle L, et al
    Plasmablastic lymphoma achieving sustained remission with antiretroviral therapy alone.
    Eur J Haematol. 2019 Sep 10. doi: 10.1111/ejh.13326.
    PubMed     Abstract available

    August 2019
  15. SINDEL A, Taylor T, Chesney A, Clark W, et al
    Hematopoietic stem cell mobilization following PD-1 blockade: Cytokine release syndrome after transplantation managed with ascorbic acid.
    Eur J Haematol. 2019;103:134-136.
    PubMed     Abstract available

    July 2019
  16. ZHOU X, Wuchter P, Egerer G, Kriegsmann M, et al
    Role of Virological Serum Markers in patients with both Hepatitis B virus infection and Diffuse Large B-cell Lymphoma.
    Eur J Haematol. 2019 Jul 23. doi: 10.1111/ejh.13300.
    PubMed     Abstract available

  17. KNAUF W, Abenhardt W, Mohm J, Rauh J, et al
    Similar effectiveness of R-CHOP-14 and -21 in diffuse large B-cell lymphoma - Data from the prospective German Tumour Registry Lymphatic Neoplasms.
    Eur J Haematol. 2019 Jul 17. doi: 10.1111/ejh.13295.
    PubMed     Abstract available

    June 2019
  18. KEANE C, Tobin J, Gunawardana J, Francis S, et al
    The tumor microenvironment is immuno-tolerogenic and a principal determinant of patient outcome in EBV positive Diffuse Large B Cell Lymphoma.
    Eur J Haematol. 2019 Jun 18. doi: 10.1111/ejh.13274.
    PubMed     Abstract available

  19. WANG L, Peng S, Sun W, Liu X, et al
    Bevacizumab synergizes with the BCL 2 inhibitor venetoclax to effectively treat B-cell non-Hodgkin's lymphoma.
    Eur J Haematol. 2019 Jun 18. doi: 10.1111/ejh.13279.
    PubMed     Abstract available

  20. HEGER JM, Eichenauer DA, Kasper P, Boll B, et al
    Fatal disseminated enterovirus infection in a patient with follicular lymphoma undergoing obinutuzumab maintenance therapy.
    Eur J Haematol. 2019 Jun 18. doi: 10.1111/ejh.13278.
    PubMed     Abstract available

  21. DADA R
    Diagnosis and management of follicular lymphoma: A comprehensive review.
    Eur J Haematol. 2019 Jun 10. doi: 10.1111/ejh.13271.
    PubMed     Abstract available

  22. MILUNOVIC V, Misura Jakobac K, Kursar M, Mandac Rogulj I, et al
    FDA's and EMA's approval of brentuximab vedotin for advanced Hodgkin lymphoma: another player in the town?
    Eur J Haematol. 2019 Jun 5. doi: 10.1111/ejh.13269.
    PubMed     Abstract available

    April 2019
  23. CRICKX E, Poullot E, Moulis G, Goulabchand R, et al
    Clinical spectrum, evolution and management of autoimmune cytopenias associated with angioimmunoblastic T-cell lymphoma.
    Eur J Haematol. 2019 Apr 15. doi: 10.1111/ejh.13239.
    PubMed     Abstract available

  24. FERRARO MP, Gimeno-Vazquez E, Subirana I, Gomez M, et al
    Anthracycline-induced cardiotoxicity in diffuse large B-cell lymphoma: NT-proBNP and cardiovascular score for risk stratification.
    Eur J Haematol. 2019 Apr 10. doi: 10.1111/ejh.13234.
    PubMed     Abstract available

    March 2019
  25. VAHAMURTO P, Mannisto S, Pollari M, Karjalainen-Lindsberg ML, et al
    Clinical features and outcome of the patients with sinonasal tract diffuse large B-cell lymphoma in the pre and rituximab eras.
    Eur J Haematol. 2019 Mar 4. doi: 10.1111/ejh.13225.
    PubMed     Abstract available

    February 2019
  26. ISHITSUKA K, Yurimoto S, Tsuji Y, Iwabuchi M, et al
    Safety and effectiveness of mogamulizumab in relapsed or refractory adult T-cell leukemia-lymphoma.
    Eur J Haematol. 2019 Feb 10. doi: 10.1111/ejh.13220.
    PubMed     Abstract available

  27. PEDERSEN MO, Gang AO, Linde EC, Breinholt MF, et al
    Stratification by MYC expression has prognostic impact in MYC/BCL2 translocated B-cell lymphoma - identifies a subgroup of patients with poor outcome.
    Eur J Haematol. 2019 Feb 9. doi: 10.1111/ejh.13219.
    PubMed     Abstract available

    November 2018
  28. SAKAROU M, Eisele L, Duhrsen U, Huttmann A, et al
    Efficacy of the GMALL-B-ALL/NHL2002 Protocol in Burkitt Leukaemia/Lymphoma and Aggressive Non-Hodgkin-Lymphomas with or without CNS-Involvement.
    Eur J Haematol. 2018 Nov 24. doi: 10.1111/ejh.13199.
    PubMed     Abstract available

  29. YONESE I, Takase H, Yoshimori M, Onozawa E, et al
    CD79B mutations in primary vitreoretinal lymphoma: Diagnostic and prognostic potential.
    Eur J Haematol. 2018 Nov 2. doi: 10.1111/ejh.13191.
    PubMed     Abstract available

    October 2018
  30. WOLFF T, Schulz H, Losem C, Reichert D, et al
    Prophylaxis of Chemotherapy-induced Neutropenia and Febrile Neutropenia with Lipegfilgrastim in Patients with Non-Hodgkin Lymphoma (NADIR study).
    Eur J Haematol. 2018 Oct 22. doi: 10.1111/ejh.13189.
    PubMed     Abstract available

  31. DADA R, Usman B
    Allogeneic hematopoietic stem cell transplantation in r/r Hodgkin lymphoma after treatment with checkpoint-inhibitors: feasibility and safety.
    Eur J Haematol. 2018 Oct 20. doi: 10.1111/ejh.13186.
    PubMed     Abstract available

    July 2018
  32. KRIEGSMANN K, Wack M, Kriegsmann M, Cremer M, et al
    Selective Contrast-enhanced Computed Tomography is Appropriate in Diffuse Large B-cell Lymphoma Therapy Response Assessment.
    Eur J Haematol. 2018 Jul 26. doi: 10.1111/ejh.13150.
    PubMed     Abstract available

  33. REPETTO-LLAMAZARES AHV, Malenge MM, O'Shea A, Eiriksdottir B, et al
    Combination of (177) Lu-lilotomab with rituximab significantly improves the therapeutic outcome in pre-clinical models of non-Hodgkin's lymphoma.
    Eur J Haematol. 2018 Jul 11. doi: 10.1111/ejh.13139.
    PubMed     Abstract available

  34. SPUKTI EU, Schmidt LH, Schulze A, Schliemann C, et al
    (90) Y-ibritumomab-tiuxetan as a therapeutic alternative for Follicular lymphoma (FL): A single-center experience.
    Eur J Haematol. 2018 Jul 11. doi: 10.1111/ejh.13138.
    PubMed     Abstract available

    June 2018
  35. SU YJ, Wang PN, Chang H, Shih LY, et al
    Extranodal NK/T Cell Lymphoma, Nasal Type: Clinical Features, Outcome and Prognostic Factors in 101 Cases.
    Eur J Haematol. 2018 Jun 16. doi: 10.1111/ejh.13126.
    PubMed     Abstract available

  36. ZHOU LL, Xu XY, Ni J, Zhao X, et al
    T-cell lymphomas associated gene expression signature: Bioinformatics analysis based on gene expression Omnibus.
    Eur J Haematol. 2018;100:575-583.
    PubMed     Abstract available

    May 2018
  37. NOESSLINGER T, Panny M, Simanek R, Moestl M, et al
    High dose Bendamustine-EAM followed by autologous stem cell rescue results in long term remission rates in lymphoma patients, without renal toxicty.
    Eur J Haematol. 2018 May 25. doi: 10.1111/ejh.13102.
    PubMed     Abstract available

  38. SORIGUE M, Tuset V, Sancho JM
    Treatment of localized-stage follicular lymphoma.
    Eur J Haematol. 2018 May 12. doi: 10.1111/ejh.13093.
    PubMed     Abstract available

  39. BJORKHOLM M, Weibull CE, Eloranta S, Smedby KE, et al
    Greater attention should be paid to developing therapies for elderly patients with Hodgkin lymphoma - a population-based study from Sweden.
    Eur J Haematol. 2018 May 4. doi: 10.1111/ejh.13090.
    PubMed     Abstract available

  40. GOLSTEIN S, Muylle K, Vercruyssen M, Spilleboudt C, et al
    Long-term follow-up of 2 patients treated with (90) Y-rituximab Radioimmunotherapy for relapse of nodular lymphocyte-predominant Hodgkin lymphoma.
    Eur J Haematol. 2018 May 2. doi: 10.1111/ejh.13087.
    PubMed     Abstract available

    April 2018
  41. MEISTER A, Hentrich M, Wyen C, Hubel K, et al
    Malignant lymphoma in the HIV-positive patient.
    Eur J Haematol. 2018 Apr 16. doi: 10.1111/ejh.13082.
    PubMed     Abstract available

  42. GRIGNANO E, Laurent J, Deau B, Burroni B, et al
    The role of radiotherapy as salvage and/or consolidation treatment in relapsed/refractory and high risk diffuse large B-cell lymphoma.
    Eur J Haematol. 2018 Apr 16. doi: 10.1111/ejh.13080.
    PubMed     Abstract available

  43. TERZIEV D, Hutter B, Klink B, Stenzinger A, et al
    Nivolumab maintenance after salvage autologous stem cell transplantation results in long term remission in multiple relapsed primary cns lymphoma.
    Eur J Haematol. 2018 Apr 6. doi: 10.1111/ejh.13072.
    PubMed     Abstract available

    March 2018
  44. CHENG CL, Liu JH, Chou SC, Yao M, et al
    Retrospective analysis of front line treatment efficacy in elderly patients with diffuse large B-cell lymphoma.
    Eur J Haematol. 2018 Mar 30. doi: 10.1111/ejh.13069.
    PubMed     Abstract available

  45. KRIEGSMANN K, Rieger M, Schwarzbich MA, Sitter S, et al
    Outcome after high-dose chemotherapy and autologous stem cell transplantation in patients with aggressive B-cell non-Hodgkin's lymphoma.
    Eur J Haematol. 2018 Mar 25. doi: 10.1111/ejh.13064.
    PubMed     Abstract available

  46. LAKSHMAIAH KC, Asati V, Babu KG, Lokanath D, et al
    Role of prephase treatment prior to definitive chemotherapy in patients with diffuse large B-cell lymphoma.
    Eur J Haematol. 2018 Mar 22. doi: 10.1111/ejh.13068.
    PubMed     Abstract available

  47. GASCON P, Krendyukov A, Hobel N, Aapro M, et al
    MONITOR-GCSF DLBCL subanalysis: Treatment patterns/outcomes with biosimilar filgrastim for chemotherapy-induced/febrile neutropenia prophylaxis.
    Eur J Haematol. 2018;100:241-246.
    PubMed     Abstract available

    February 2018
  48. BOUTSIKAS G, Terpos E, Papatheodorou A, Tsirkinidis P, et al
    Study of bone metabolism and angiogenesis in patients undergoing high-dose chemotherapy/autologous hematopoietic stem cell transplantation.
    Eur J Haematol. 2018;100:131-139.
    PubMed     Abstract available

    January 2018
  49. TANAKA Y, Maeshima AM, Nomoto J, Makita S, et al
    Expression pattern of PD-L1 and PD-L2 in classical Hodgkin lymphoma, primary mediastinal large B-cell lymphoma, and gray zone lymphoma.
    Eur J Haematol. 2018 Jan 28. doi: 10.1111/ejh.13033.
    PubMed     Abstract available

    December 2017
  50. JAMROZIAK K, Szymczyk A, Hus M, Wojciechowska M, et al
    Hodgkin's variant of Richter's transformation during ibrutinib therapy in a series of CLL patients; the Polish Adult Leukemia Group report (PALG).
    Eur J Haematol. 2017 Dec 15. doi: 10.1111/ejh.13016.
    PubMed     Abstract available

    November 2017
  51. LI JW, Li YJ, Zhong MZ, Liu XL, et al
    Efficacy and tolerance of GELOXD/P-GEMOXD in newly diagnosed nasal-type extranodal NK/T-Cell lymphoma: A multicenter retrospective study.
    Eur J Haematol. 2017 Nov 30. doi: 10.1111/ejh.13004.
    PubMed     Abstract available

  52. SCHILLER J, Klein S, Engels M, Buttner R, et al
    A Cryptosporidium infection in a patient with relapsed T lymphoblastic lymphoma undergoing allogeneic stem cell transplantation.
    Eur J Haematol. 2017 Nov 15. doi: 10.1111/ejh.12998.
    PubMed     Abstract available

    October 2017
  53. HOLLANDER P, Rostgaard K, Smedby KE, Molin D, et al
    An anergic immune signature in the tumor microenvironment of classical Hodgkin lymphoma is associated with inferior outcome.
    Eur J Haematol. 2017 Oct 24. doi: 10.1111/ejh.12987.
    PubMed     Abstract available

  54. ELORANTA S, Branvall E, Celsing F, Papworth K, et al
    Increasing incidence of Primary CNS lymphoma but no improvement in survival in Sweden 2000-2013.
    Eur J Haematol. 2017 Oct 6. doi: 10.1111/ejh.12980.
    PubMed     Abstract available

    September 2017
  55. BROCKELMANN PJ, Zagadailov EA, Corman SL, Chirikov V, et al
    Brentuximab Vedotin in Patients with Relapsed or Refractory Hodgkin Lymphoma who are Ineligible for Autologous Stem Cell Transplant: A Germany and UK Retrospective Study.
    Eur J Haematol. 2017 Sep 26. doi: 10.1111/ejh.12973.
    PubMed     Abstract available

    June 2017
  56. CAMPIONI D, Gentili V, Cavazzini F, Bortolotti D, et al
    Detection of inherited chromosomally integrated HHV-6 (ciHHV-6) in a marker chromosome.
    Eur J Haematol. 2017;98:635-637.
    PubMed     Abstract available

    May 2017
  57. GLAVEY S, Quinn J, McCloy M, Sargent J, et al
    Emergence of Bruton's Tyrosine Kinase-negative Hodgkin Lymphoma During Ibrutinib Treatment of Chronic Lymphocytic Leukaemia.
    Eur J Haematol. 2017 May 31. doi: 10.1111/ejh.12911.
    PubMed     Abstract available

  58. KAWAMOTO K, Miyoshi H, Yanagida E, Yoshida N, et al
    Comparison of clinicopathological characteristics between T-cell prolymphocytic leukemia and peripheral T-cell lymphoma, not otherwise specified.
    Eur J Haematol. 2017;98:459-466.
    PubMed     Abstract available

    February 2017
  59. THOTA S, Advani A
    Inotuzumab ozogamicin in relapsed b-cell acute lymphoblastic leukemia.
    Eur J Haematol. 2017 Feb 2. doi: 10.1111/ejh.12862.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Malignant Lymphoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.